Taiwan FDA registration ca2c6dae719ffcd0c3d3ea156ea1dba7
Shibo Urine Liquid Trial
TW: 思博 尿液試紙
Taiwan·Risk Class 2·DFI CO.,Ltd·Registered May 05, 2021 – May 05, 2026ExpiredRegistration details
- Analysis ID
- ca2c6dae719ffcd0c3d3ea156ea1dba7
- Customs Code
- DHA05603464501
Company information
- Manufacturer
- DFI CO.,Ltd
- Manufacturer Country
- Korea, Republic of
- Authorized Representative
- BIOCARE CORPORATION
Product details
- Intended Use
- This product is used for rapid detection of urobilinogen, glucose, bilirubin, ketone bodies (acetoacetic acid), urine specific gravity, urine occult blood, pH, urine protein, nitrite, white blood cells, microalbumin and creatine acyl.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1645 Urine protein or albumin (non-quantitative) testing system; A.1115 Urine bilirubin and its conjugates (non-quantitative) test system;; A.1340 Urine glucose (non-quantitative) test system
- Import Information
- Input;; QMS/QSD
Dates and status
- Registration Date
- May 05, 2021
- Expiry Date
- May 05, 2026
About this record
Access comprehensive regulatory information for Shibo Urine Liquid Trial in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ca2c6dae719ffcd0c3d3ea156ea1dba7 and manufactured by DFI CO.,Ltd. The authorized representative in Taiwan is BIOCARE CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices